Personalised, Rational, Efficacy-Driven Cancer Drug Dosing via an Artificial Intelligence SystEm (PRECISE): A Protocol for the PRECISE CURATE.AI Pilot Clinical Trial

Introduction: Oncologists have traditionally administered the maximum tolerated doses of drugs in chemotherapy. However, these toxicity-guided doses may lead to suboptimal efficacy. CURATE.AI is an indication-agnostic, mechanism-independent and efficacy-driven personalised dosing platform that may o...

Descrición completa

Detalles Bibliográficos

Principais autores:	Benjamin Kye Jyn Tan, Chong Boon Teo, Xavier Tadeo, Siyu Peng, Hazel Pei Lin Soh, Sherry De Xuan Du, Vilianty Wen Ya Luo, Aishwarya Bandla, Raghav Sundar, Dean Ho, Theodore Wonpeum Kee, Agata Blasiak
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Digital Health
Assuntos:	clinical decision support system chemotherapy personalised medicine clinical trials artificial intelligence oncology
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fdgth.2021.635524/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!